Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Total Assets
Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) holds total assets worth CN¥35.27 Billion CNY (≈ $5.16 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Jilin Aodong Pharmaceutical Group Co Ltd (000623) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Jilin Aodong Pharmaceutical Group Co Ltd - Total Assets Trend (1993–2025)
This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See Jilin Aodong Pharmaceutical Group Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Jilin Aodong Pharmaceutical Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Jilin Aodong Pharmaceutical Group Co Ltd's total assets of CN¥35.27 Billion consist of 14.0% current assets and 86.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 3.4% |
| Accounts Receivable | CN¥666.79 Million | 1.9% |
| Inventory | CN¥802.10 Million | 2.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥439.37 Million | 1.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1993–2025)
This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jilin Aodong Pharmaceutical Group Co Ltd's current assets represent 14.0% of total assets in 2025, a decrease from 71.4% in 1993.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2025, down from 16.1% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1993.
- Asset Diversification: The largest asset category is inventory at 2.3% of total assets.
Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Total Assets
Key competitors of Jilin Aodong Pharmaceutical Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | Rs443.12 Billion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥11.40 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
Jilin Aodong Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.38 | 1.87 | 4.04 |
| Quick Ratio | 1.97 | 1.53 | 3.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.81 Billion | CN¥2.25 Billion | CN¥4.98 Billion |
Jilin Aodong Pharmaceutical Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Jilin Aodong Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.63 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | 4.3% |
| Total Assets | CN¥34.42 Billion |
| Market Capitalization | $3.09 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Jilin Aodong Pharmaceutical Group Co Ltd's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jilin Aodong Pharmaceutical Group Co Ltd's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jilin Aodong Pharmaceutical Group Co Ltd (1993–2025)
The table below shows the annual total assets of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥34.42 Billion ≈ $5.04 Billion |
+4.29% |
| 2024-12-31 | CN¥33.00 Billion ≈ $4.83 Billion |
+2.28% |
| 2023-12-31 | CN¥32.27 Billion ≈ $4.72 Billion |
+3.48% |
| 2022-12-31 | CN¥31.18 Billion ≈ $4.56 Billion |
+7.27% |
| 2021-12-31 | CN¥29.07 Billion ≈ $4.25 Billion |
+6.06% |
| 2020-12-31 | CN¥27.41 Billion ≈ $4.01 Billion |
+6.22% |
| 2019-12-31 | CN¥25.80 Billion ≈ $3.78 Billion |
+4.63% |
| 2018-12-31 | CN¥24.66 Billion ≈ $3.61 Billion |
+12.95% |
| 2017-12-31 | CN¥21.83 Billion ≈ $3.19 Billion |
+7.33% |
| 2016-12-31 | CN¥20.34 Billion ≈ $2.98 Billion |
+2.55% |
| 2015-12-31 | CN¥19.83 Billion ≈ $2.90 Billion |
+44.04% |
| 2014-12-31 | CN¥13.77 Billion ≈ $2.01 Billion |
+13.74% |
| 2013-12-31 | CN¥12.11 Billion ≈ $1.77 Billion |
+10.44% |
| 2012-12-31 | CN¥10.96 Billion ≈ $1.60 Billion |
+8.74% |
| 2011-12-31 | CN¥10.08 Billion ≈ $1.48 Billion |
+27.63% |
| 2010-12-31 | CN¥7.90 Billion ≈ $1.16 Billion |
+10.28% |
| 2009-12-31 | CN¥7.16 Billion ≈ $1.05 Billion |
+23.97% |
| 2008-12-31 | CN¥5.78 Billion ≈ $845.44 Million |
+2.47% |
| 2007-12-31 | CN¥5.64 Billion ≈ $825.09 Million |
+71.92% |
| 2006-12-31 | CN¥3.28 Billion ≈ $479.92 Million |
+30.10% |
| 2005-12-31 | CN¥2.52 Billion ≈ $368.89 Million |
-0.04% |
| 2004-12-31 | CN¥2.52 Billion ≈ $369.05 Million |
+29.26% |
| 2003-12-31 | CN¥1.95 Billion ≈ $285.52 Million |
+3.70% |
| 2002-12-31 | CN¥1.88 Billion ≈ $275.33 Million |
+11.21% |
| 2001-12-31 | CN¥1.69 Billion ≈ $247.58 Million |
+18.64% |
| 2000-12-31 | CN¥1.43 Billion ≈ $208.68 Million |
+22.65% |
| 1999-12-31 | CN¥1.16 Billion ≈ $170.14 Million |
+40.46% |
| 1998-12-31 | CN¥827.80 Million ≈ $121.13 Million |
+48.35% |
| 1997-12-31 | CN¥558.00 Million ≈ $81.65 Million |
+32.41% |
| 1996-12-31 | CN¥421.43 Million ≈ $61.67 Million |
+70.42% |
| 1995-12-31 | CN¥247.29 Million ≈ $36.19 Million |
+14.97% |
| 1994-12-31 | CN¥215.10 Million ≈ $31.48 Million |
+4.21% |
| 1993-12-31 | CN¥206.42 Million ≈ $30.21 Million |
-- |
About Jilin Aodong Pharmaceutical Group Co Ltd
Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction … Read more